Similar articles

• Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign.

  Uhari M, Rantala H, Niemelä M. Uhari M, et al. Lancet. 1989 Aug 19;2(8660):440-1. doi: 10.1016/s0140-6736(89)90609-0. Lancet. 1989. PMID: 2569613 No abstract available.
• Safety aspects of oral poliovirus vaccine campaigns.

  Hovi T. Hovi T. Dev Biol Stand. 1995;84:137-44. Dev Biol Stand. 1995. PMID: 7796946 Review. No abstract available.
• Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.

  Rantala H, Cherry JD, Shields WD, Uhari M. Rantala H, et al. J Pediatr. 1994 Feb;124(2):220-3. doi: 10.1016/s0022-3476(94)70307-8. J Pediatr. 1994. PMID: 8301426
• Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign.

  Kinnunen E, Färkkilä M, Hovi T, Juntunen J, Weckström P. Kinnunen E, et al. Neurology. 1989 Aug;39(8):1034-6. doi: 10.1212/wnl.39.8.1034. Neurology. 1989. PMID: 2788248
• [Universal use of inactivated poliovirus vaccine--the needs and challenges].

  Shimizu H, Takeda N. Shimizu H, et al. Nihon Rinsho. 2008 Oct;66(10):1950-5. Nihon Rinsho. 2008. PMID: 18939495 Review. Japanese.